title: Loss of p16 and p27 is associated with progression of human gastric cancer.
abstract: We performed the immunohistochemical staining for six G1 check point cell cycle proteins to study their expression patterns and roles in the gastric carcinogenesis. We studied 76 cases of paraffin blocks that included the sections of 18 tubular adenomas (TA), 38 early gastric carcinomas (EGC) (20 cases of mucosal type, nine cases of submucosal type with no nodal metastasis, nine cases of submucosal type with nodal metastasis), 20 advanced gastric carcinomas (AGC) (ten cases with no nodal metastasis, ten cases with nodal metastasis). We found that abnormal expression of p16 and p27 increased with the progression of tubular adenomas to advanced gastric cancers. Inverse relationship between pRb and p16 proteins was found in a small portion of the gastric tumors. Expressions of pRb and cdk4 were consistently high in benign and malignant gastric tumors. Expression of cyclin D1 and cyclin E rather decreased with the tumor progression. In conclusion, losses of p16 and p27 seem to play a significant role during the gastric carcinogenesis, and the G1 checkpoint cell cycle proteins such as pRb, cdk4, cyclin D1, and cyclin E variably participate in the gastric carcinogenesis and metastasis by the mechanisms which are yet unknown; thus, further studies need to be performed to elucidate the mechanisms.
authors.affiliation: Department of Pathology, DanKook University, College of Medicine, Cheonan, South Korea.
authors.forename: N
authors.initials: N
authors.lastname: Myung
authors.forename: M R
authors.initials: MR
authors.lastname: Kim
authors.forename: I P
authors.initials: IP
authors.lastname: Chung
authors.forename: H
authors.initials: H
authors.lastname: Kim
authors.forename: J J
authors.initials: JJ
authors.lastname: Jang
mesh_terms: D014408:Biomarkers, Tumor / Q000096:biosynthesis* / Q000172:deficiency; D018797:Cell Cycle Proteins / Q000032:analysis; D019938:Cyclin D1 / Q000032:analysis; D019927:Cyclin E / Q000032:analysis; D051358:Cyclin-Dependent Kinase 4; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000096:biosynthesis / Q000172:deficiency / Q000502:physiology*; D050760:Cyclin-Dependent Kinase Inhibitor p27; D018844:Cyclin-Dependent Kinases / Q000032:analysis; D018450:Disease Progression; D016193:G1 Phase; D006801:Humans; D007150:Immunohistochemistry; D008869:Microtubule-Associated Proteins / Q000096:biosynthesis / Q000172:deficiency / Q000502:physiology*; D011379:Prognosis; D011518:Proto-Oncogene Proteins; D016160:Retinoblastoma Protein / Q000032:analysis; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D025521:Tumor Suppressor Proteins
chemical_list: D014408:Biomarkers, Tumor; D018797:Cell Cycle Proteins; D019927:Cyclin E; D019941:Cyclin-Dependent Kinase Inhibitor p16; D008869:Microtubule-Associated Proteins; D011518:Proto-Oncogene Proteins; D016160:Retinoblastoma Protein; D025521:Tumor Suppressor Proteins; D019938:Cyclin D1; D050760:Cyclin-Dependent Kinase Inhibitor p27; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases